Citadel Advisors »

Evogene shares owned by Citadel Advisors

Quarter-by-quarter ownership of Evogene (EVGN) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Evogene

Tip: Access up to 7 years of quarterly data

All positions including Evogene held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evogene by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $66k 58k 1.14
2025-06-30 $27k 21k 1.28
2024-12-31 $30k 16k 1.87

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Evogene

Citadel Advisors
Jane Street
Morgan Stanley
Two Sigma Securities
Bnp Paribas Arbitrage, Snc
UBS Group
Altshuler Shaham
SBI Securities
Steward Partners Investment Advisory
Federation des caisses Desjardins du Quebec
Tradewinds Capital Management
Advisor Group Holdings
Royal Bank of Canada

View all funds holding Evogene